- Academic Editor
†These authors contributed equally.
Background: The matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that play a variety of physiological and pathological roles in development, remodeling of tissues and diseases, mainly through degradation of various components of the extracellular matrix (ECM). Particularly, the MMPs have increasingly been found to mediate neuropathology following spinal cord injury (SCI). Proinflammatory mediators are potent activators of the MMPs. However, how the spinal cord regenerative vertebrates circumvent MMPs-mediated neuropathogenesis following SCI remains unclear. Methods: Following the establishment of gecko tail amputation model, the correlation of MMP-1 (gMMP-1) and MMP-3 (gMMP-3) expression with that of macrophage migration inhibitory factor in gecko (gMIF) was assayed by RT-PCR, Western blot and immunohistochemistry. Transcriptome sequencing of primary astrocytes was performed to analyze the intracellular signal transduction of macrophage migration inhibitory factor (MIF). The effects of MMP-1 and MMP-3 induced by MIF on astrocyte migration were assessed by transwell migration assay. Results: The expression of gMIF significantly increased at lesion site of the injured cord, in parallel with those of gMMP-1 and gMMP-3 in the gecko astrocytes (gAS). Transcriptome sequencing and in vitro cell model revealed that gMIF efficiently promoted the expression of gMMP-1 and gMMP-3 in gAS, which in turn contributed to the migration of gAS. Inhibition of gMIF activity following gecko SCI remarkably attenuated astrocytic expression of the two MMPs, and further influenced gecko tail regeneration. Conclusions: Gecko SCI following tail amputation promoted production of gMIF, which induced the expression of gMMP-1 and gMMP-3 in gAS. The gMIF-mediated gMMP-1 and gMMP-3 expression was involved in gAS migration and successful tail regeneration.
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases involved in proteolytic degradation of extracellular matrix (ECM) including collagen, fibronectin and proteoglycan. Also, MMPs can liberate biologically active proteins such as cytokines, growth factors, chemokines and several proproteinases from their inert proforms [1, 2]. These significant properties of MMPs endow them with a variety of regulatory roles in physiological and pathological processes, such as in tissue remodeling and organ development, in regulation of wound healing, tissue regeneration, angiogenesis, inflammation, as well as tumor progression [3, 4, 5, 6, 7]. The activity of MMPs is closely regulated by transcription level, pro-MMP activation, and inhibition by endogenous inhibitors [8]. Imbalance of the homeostatic regulation of MMPs will results in uncontrolled ECM related diseases, such as tissue ulceration, pulmonary disease, nephritis, arthritis, cardiovascular disease, cancer and neurological disorders [9, 10, 11, 12]. To date, at least 28 different types of MMPs have been identified and categorized into four classes according to their substrate specificity, the collagenases, the gelatinases, the stromelysins and a heterogeneous group [13]. All of them consist of a pro-peptide, a catalytic domain, and a hemopexin domain that is linked to the catalytic domain via a flexible hinge region [14]. Only after proteolytic removal of the pro-domain or chemical modification of the cysteine residue in the pro-peptide, the MMPs become proteolytically active and mediates turnover of ECM [2].
MMP-1 mainly degrades types I, II and III collagens, but also participates in hydrolyzing other ECM molecules and soluble proteins [15, 16]. Like other MMPs, MMP-1 plays an important role in development, tissue morphogenesis and wound repair [17, 18]. Generally, MMP-1 maintains at a low level in physiological conditions, and is dramatically induced in response to pathological conditions such as oxidative stress, inflammatory stimulation and tissue remodeling [19]. The abnormal activity of MMP-1 is closely associated with the occurrence of tumors, arthritis, emphysema and fibrosis [20, 21]. In the central nervous system (CNS), MMP-1 is involved in neurodegenerative diseases, such as Alzheimer’s disease (AD), and Amyotrophic Lateral Sclerosis (ALS) [22]. Inflammatory cytokines have been shown to induce up-regulation of MMP-1 in astrocytes, contributing to neuronal apoptosis and changes in functional circuits [23, 24]. It is interesting to note that MMP-1 favors spinal cord regeneration of amphibians by promoting the migration of ependymal cells [18]. Therefore, MMP-1-mediated pathological function in CNS is species-specific across phylogeny. Another family member MMP-3 belongs to the stromelysin-subgroup that can activate various growth factors, cell adhesion molecules, cytokines, chemokines and receptors other than the ECM [6]. In addition, MMP-3 exhibits proteolytic activity towards other subfamily members including pro-MMP-1, -3, -7, -8, -9 and -13, as well as its upstream activators, such as fibrinogen and urokinase plasminogen activator [25, 26]. Similarly, MMP-3 not only participates in body development and tissue repair, but also plays multiple pathophysiological roles including tumorigenesis, osteoarthritis, rheumatoid arthritis and other diseases [10, 27]. After CNS insults, MMP-3 is inducibly expressed by damaged neurons, astrocytes, oligodendrocytes, microglia/macrophages, and vascular endothelial cells [28]. The dysregulated MMP-3 aggravates a variety of neurodegenerative diseases by disrupting the blood-brain barrier (BBB), promoting apoptosis of neurons and oligodendrocytes, or stimulating excessive inflammatory responses [29, 30]. Conversely, MMP-3 promotes neuronal migration, neurite outgrowth and myelinogenesis in the developing CNS [25].
Proinflammatory cytokines including TNF-
Unlike mammals, several vertebrates including fish, amphibian and lizards can regenerate spinal cord following injury [39]. The regenerative process is driven under restricted inflammation and astrocyte reactivity [40, 41, 42]. Axonal elongation is observed along a “glial bridge” built by a population of glial cells at the lesion site [43, 44]. The oriented migration of astrocytes, however, plays important role in supporting the regeneration of the spinal cord. MIF is also upregulated by the cord injury, but it cannot evoke the inflammation during the spontaneous spinal cord regeneration [45]. In the meantime, the MMPs, including MMP-1 and MMP-3, are found to be involved in mediating migration and differentiation of ependymal cells and blastemal cells [17, 46]. These lines of evidence suggest that increased activity of MMP-1 and MMP-3 is necessary for either spinal cord or appendage regeneration [18]. Given that MIF has been shown to closely associate with the malignant progression of a variety of human carcinomas by regulation of several MMPs, it is therefore assumed that MIF may promote expression of MMP-1 and MMP-3 to mediate astrocytic migration during the spontaneous spinal cord regeneration [47]. In the present study, Gekko japonicus was used as the experimental SCI model to investigate the regulatory function of MIF on MMP-1 and MMP-3 in astrocytes. Our results demonstrated that MIF efficiently induced the expression of MMP-1 and MMP-3 in astrocytes and promoted cell migration after gecko SCI. MIF inhibitor 4-IPP significantly inhibited regeneration of amputated tail, which might provide an important clue for understanding the distinct function of MMP-1 and MMP-3 in tissue repair among different species.
Adult Gekko japonicus was used as experimental models as described by Dong et al. [48]. Geckos were housed in the room with humidity- and temperature-controlled and fed with water and mealworms (22–25 °C). To mimic the autotomy in the natural environment, gecko tail amputation was performed at the sixth caudal vertebra according to the unique body structure [49]. The animals were anesthetized by freezing on ice before sacrifice. The number of gecko subjected to amputation was calculated by six per experimental group in triplicate. All experimental protocols were approved by the Animal Ethics Committee of Nantong University.
Injections of 4
The amino acid sequences of gecko MMP-1 (gMMP-1) and MMP-3 (gMMP-3) were obtained from the National Center for Biotechnology Information [50]. MegAlign program with the Clustal X 2.0 (http://www.clustal.org/clustal2/) method was used for alignment of multiple protein sequences [51].
Astrocytes (gAS) were isolated and cultured from the spinal cord of adult gecko
according to previously described methods [52]. Briefly, the cells were
dissociated using 0.25% trypsin (Gibco-BRL, Grand Island, NY, USA) for 20 min at
30
Total RNA of gAS stimulated with 2.5
Differentially expressed mRNA was designated in criteria of greater or less than
twofold changes in comparison with control. Function of genes was annotated by
Blastx against the NCBI database or the AGRIS database
(http://arabidopsis.med.ohio-state.edu/downloads.html) with E-value threshold of
10
Proteins were extracted from 0.5 cm gecko cord segments above the amputation
site or from cultured cells with RIPA lysis buffer (Beyotime, Shanghai, China).
The protein concentration of each sample was detected by BCA kit (Beyotime). The
extracts were heat-denatured at 95 °C for 5 min, electrophoretically resolved by
10% SDS-PAGE, and transferred to PVDF membranes. The membranes were incubated
with primary antibodies in TBS buffer at 4 °C for 18 h, followed with a
HRP-conjugated secondary antibody (1:1000, Proteintech Group, Inc., Chicago, IL,
USA) at room temperature for 2 h. The signal of HRP activity was detected using
an ECL detection kit (Vazyme, Nanjing, Jiangsu, China). Antibodies used in
Western blot were:
Total RNA was prepared with Trizol (Thermo Fisher Scientific, Waltham, MA, USA)
from gecko cord segments or cultured cells as mentioned above. The first-strand
cDNA was synthesized using HisScript Ⅱ Q Select RT SuperMix for qPCR (R223-01, Vazyme, Nanjing, China) in
a 20-
The transverse sections from the spinal cord segments or the cultured cells were
incubated with S100
The migration of gAS was assayed in triplicates using 24-well transwell chambers
with 8
Differences between groups were analyzed by one-way analysis of variance with
SPSS 23 software (SPSS, Chicago, IL, USA). Normality and homoscedasticity of the
data were verified using Levene’s test before statistical analysis. p
To understand the physiological functions of MMP-1 and MMP-3 in gecko after tail amputation, we analyzed the structural characteristics of gMMP-1 (GenBank: XP_015277097) and gMMP-3 (GenBank: XP_015277100) amino acids sequence. The gMMP-1 is composed of 378, while gMMP-3 480 amino acids (Fig. 1). Both matrix metalloproteinases contain a signal peptide, a pro-peptide with a cysteine switch, a catalytic domain and a hemopexin domain, suggesting the conserved primary structure of MMPs in the vertebrates (Fig. 1).

Sequence analysis of gMMP-1 and gMMP-3. Multiple alignment of amino acid sequences of gMMP-1 and gMMP-3 with the sequences of other representative vertebrates. Gaps introduced into sequences to optimize alignment are represented by dashes. Signal peptide, Pro-peptide, Catalytic domain, Cysteine Switch motif, Zinc-binding domain, Hinge domain and Hemopexin domain are indicated. Sequences obtained from GenBank: gecko-MMP-1 (XP_015277097), mouse-MMP-1 (NP_032633.1), human-MMP-1 (AIC54763.1), gecko-MMP-3 (XP_015277100), mouse-MMP-3 (NP_034939.1) and human-MMP-3 (NP_002413.1).
To clarify the potential roles of gMMP-1 and gMMP-3 in the injured spinal cord,
a 0.5-cm cord segment at lesion site was collected at 0 d, 1 d, 3 d and 7 d after
gecko tail amputation. The expression of gMMP-1 and gMMP-3 was
detected by RT-PCR, showing that both MMPs transcription dramatically increased
from 1 d with a peak at 3 d, and returned to the control level at 7 d (Fig. 2A,B). Immunostaining was then carried out to observe whether gAS was involved in
the production of gMMP-1 and gMMP-3 in response to SCI. Results indicated that
gecko SCI significantly induced the astrocytic expression of gMMP-1 and gMMP-3,
as were analyzed by the colocalization of S100

Determination of gMMP-1 and gMMP-3 in the injured spinal cord of
gecko. (A,B) RT-PCR analysis of gMMP-1 and gMMP-3 in the 0.5
cm segments of the injured cord following gecko tail amputation (n = 6) at 0 d, 1
d, 3 d and 7 d, respectively. (C) Immunofluorescence showed the colocalization of
gMMP-1 (red) with S100
MMPs can be induced by various inflammatory cytokines including TNF-
To validate the regulatory roles of gMIF on the astrocytic activation of gMMP-1
and gMMP-3, the primary gAS was cultured with purity over 95% (Fig. 3A,B).
Transcriptome sequencing (RNA-Seq) was then performed following gAS stimulation
with 2.5

Transcriptome sequencing analysis of gAS following stimulation
with 2.5

Heatmap and the inferred gene network of integrated DEGs. (A)
Heatmap of integrated DEGs in response to stimulation of 2.5
To confirm the inference from RNA-Seq, the expression changes of gMMP-1 and
gMMP-3 in gAS were determined by RT-PCR following cell exposure to 0–2.5

Examination of gMMP-1 and gMMP-3 expression in astrocytes
following treatment with gradient recombinant gMIF. (A–C) Immunostaining showed
the expression of CD74, gMMP-1 and gMMP-3 in astrocytes. (D, E) RT-PCR
analysis for gMMP-1 and gMMP-3 in astrocytes following stimulation with 0–2.5
To explore the roles of gMIF-mediated gMMP-1 and gMMP-3 expression on the cell
event of gAS, the gMMP-1 or gMMP-3 was knocked down by siRNA in the presence of
gMIF. The siRNA oligonucleotides gMMP-1-s3 and gMMP-3-s2 with the highest
efficiency for interference were accordingly selected (Fig. 6A,B). The cells
were transfected with gMMP-1-s3 or gMMP-3-s2 oligonucleotides for 48 h, followed
by stimulation with 1.5

Effects of gMIF-mediated gMMP-1 and gMMP-3 expression on gAS
migration. (A, B) Interference efficiency of three siRNA oligonucleotides for
gMMP-1 and gMMP-3 was measured by RT-PCR, respectively. gMMP-1-siRNA3 and
gMMP-3-siRNA2 were selected for the knockdown experiments. (C, D) The expression
of gMMP-1 and gMMP-3 after siRNA knockdown for 48 h, followed by stimulation with
1.5
MIF influences a variety of cell behaviors through activation of intracellular
MAPKs, such as inflammatory response, cellular survival, and proliferation [59].
To unveil the potential regulatory mechanism of gMIF on the expression of gMMP-1
and gMMP-3, 2.5

Effects of gMIF on activation of intracellular MAPKs in gAS.
(A) Western blot analysis of p-JNK, p-P38 and p-ERK protein levels following
astrocytes stimulation with 2.5
To clarify the physiological significance of gMIF-regulated expression of gMMP-1
and gMMP-3, a total of 4

Inhibitor of gMIF attenuates gecko tail regeneration. (A)
Immunofluorescence of gMMP-1 and gMMP-3 expression in gAS after cord treatment
with 4-IPP or vehicle following gecko tail amputation (n = 6) at 3 d. The
rectangle indicates the region magnified. Arrowheads indicate the colocalized
signals. (B) Observation of gecko tail regeneration following injection of 4
SCI often triggers a series of molecular and cellular events, including disruption of blood spinal cord barrier, activation of excessive inflammation, apoptosis of neurons and oligodendrocytes, and formation of a permanent glial scar [60, 61, 62]. These neuropathogenesis severely hampers the functional outcomes. Damage-associated molecular patterns (DAMPs) are key mediators to initiate and accelerate the degenerative process of the injured spinal cord [22, 63]. Lines of evidence demonstrate that DAMPs elicit excessive inflammation by interacting with the pattern recognition receptors (PRRs) on the surface of microglia and astrocytes, thereby contributing to neurotoxicity [64]. MIF is recognized as an important DAMPs molecule following CNS insults. It is immediately elevated after SCI by inducibly expressed in multiple cells including the neurons, oligodendrocytes, microglia, astrocytes and vascular endothelial cells, in association with neuronal apoptosis and demyelination [35, 65]. Also, MIF is able to interact with membrane surface receptor CD74 in microglia and astrocytes to activate inflammatory and chemotactic responses [38, 66]. D-Dopachrome tautomerase (D-DT), a homolog of MIF, shares a 35% sequence similarity with MIF in human. The tautomerase enzymatic activity of D-DT is ten times less active than MIF [45, 67]. Our previous works have shown that gMIF, rather than D-DT, plays roles in promoting the spinal cord regeneration without evoking the excessive inflammation following gecko tail amputation [45, 68]. Such functions are completely opposite to what MIF acts in the mammals. Mechanistically, the gMIF-mediated inflammation is either blocked by VAV1 in astrocytes, or transformed to promoting phagocytose of microglia/macrophages [66, 68]. In the present study, we have demonstrated that gMIF promoted astrocytic migration by up-regulating the expression of MMP-1 and MMP-3 in astrocytes, suggesting the diverse roles of MIF in promoting the spontaneous spinal cord regeneration.
Astrocytes in response to SCI often become “reactive”, undergoing dramatic shifts from morphology to functions, including hypertrophy of soma, reduction of processes, susceptive to inflammatory stimuli and formation of a scar [69]. Originally, a population of reactive astrocytes with a barrier-like structure is mobilized to spatially isolate the diffusion of inflammatory factors and other toxic substances and protect injured nerves [70]. Afterwards, the reactive astrocytes form a glial scar that limits the plasticity of axons [71]. In stark contrast, certain vertebrate species, including fish and salamanders, can lead to less astrocyte reaction after SCI, although it is still controversial whether these two species have “true astrocytes” [39]. Glial cells have been found to be arranged along the injured site, creating a “glial bridge” upon which axons can grow across [39]. As a consequence, the oriented migration of astrocytes is essential for the axonal growth and successful spinal cord regeneration. SCI of gecko is similar to those of fish and amphibian in limited inflammation and absence of glial scar [42, 52]. In the present study, we showed that gMIF promoted astrocytic migration through regulation of gMMP-1 and gMMP-3, suggesting a beneficial role of astrocytes during the spontaneous spinal cord regeneration.
As important endopeptidases, MMPs mainly degrade the structural components of ECM to participate in many physiological and pathological processes, such as inflammation, wound healing, angiogenesis, cell apoptosis, and tumor invasion [3, 72]. Increasing evidence reveals that intracellular MMPs have also several alternative substrates, and play novel biological roles independent of its action on the extracellular matrix. For instance, MMP-2 located in cardiac myocytes is involved in the degradation of troponin to mediate ischemia-reperfusion injury [73]. MMP1, however, has been found to facilitate cell invasion in glioma by intracellular regulation of the MAPK pathway [74]. Similarly, MMP-3 is found in the cytoplasm and nucleus of dopamine neurons and myofibroblasts. Although the indeed substrate is unclear, MMP-3 performs in tumor progression and angiogenesis by inducing the transcription of CTGF gene [75]. In this study, we found that gMIF induced the expression of gMMP-1 and gMMP-3 in astrocytes after gecko SCI. Whether gMMP-1 and gMMP-3 can mediate cell events of astrocytes through intracellular substrates remains to be further studied.
Gecko SCI increased the protein levels of gMIF at lesion site, which significantly induced the expression of gMMP-1 and gMMP-3 in the astrocytes. The gMIF-mediated gMMP-1 and gMMP-3 activity contributed to the migration of astrocytes, which in turn were involved in the successful tail regeneration of gecko.
ANOVA, analysis of variance; MIF, macrophage migration inhibitory factor; DAMPs, damage associated molecular pattern molecules; DMEM, Dulbecco’s Modified Eagle’s Medium; PBS, phosphate buffered saline; MAPK, mitogen-activated protein kinase; SCI, spinal cord injury; GFAP, glial fibrillary acid protein; 4-IPP, 4-iodo-6-phenylpyrimidine; IPA, Ingenuity Pathway Analysis Software; Q-PCR, Quantitative real-time polymerase chain reaction.
YonW and YinW designed this work. HZ and CS performed the experiments. HZ, CS, BH, XZ, HH, YH, AL, YonW and YinW analyzed the data. HZ and YonW joined discussions. YinW wrote the paper. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.
All animal experiments were approved by the Animal Care and Use Committee of Nantong University and the Jiangsu Province Animal Care Ethics Committee (S20190420-405).
We thank all the participants in the study.
This research was funded by the National Natural Science Foundation of China (No. 31871211), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
The authors declare no conflict of interest.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.